Ratio of nuchal thickness to humerus length for Down syndrome detection

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 6, 2001, Pages 1284-1288

  Bahado Singh, Ray O ^a   Oz, Utku ^a   Hsu, Char Dong ^a   Deren, Ozgur ^a   Copel, Joshua A ^a   Mahoney, Maurice J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Down syndrome; Humerus length; Nuchal thickness

Indexed keywords

ADULT; ALGORITHM; AMNIOCENTESIS; ARTICLE; BIOMETRY; BIPARIETAL DISTANCE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FETUS; FETUS ECHOGRAPHY; HIGH RISK POPULATION; HUMAN; HUMERUS; KARYOTYPE; MAJOR CLINICAL STUDY; MATERNAL AGE; MORPHOMETRICS; NECK; PRIORITY JOURNAL; SCREENING;

EID: 0035341061     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.113878     Document Type: Article

References (14)

1. Persutte WH, Hobbins JC, Nyberg DA, Bahado-Singh R, Hill LM, Abuhamad A, et al. Trisomy 21 multicenter collaborative project [abstract 47]. Am J Obstet Gynecol 1998;178(1 Pt 2):S22.
2. Vintzileos AM, Guzman ER, Smulian JC, McLean DA, Ananth CV. Choice of second-trimester sonogram for detection of trisomy 21. Obstet Gynecol 1997;90:L187-90.
3. Bahado-Singh R, Deren O, Oz U, Tan A, Hunter D, Copel J, et al. An alternative for women initially declining genetic amniocentesis: Individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers. Am J Obstet Gynecol 1998;179:514-9.
4. Gray DL, Crane JP. Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of Down syndrome. Am J Obstet Gynecol 1994;171:1282-6.
5. Reynolds TM, Penney MD. The mathematical basis of multivariate screening with special reference to screening for Down's syndrome associated pregnancy. Ann Clin Biochem 1990;27:452-8.
6. Palomaki GE, Haddow JE. Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol 1987;156:460-3.
7. Zweig MH, Campbell G. Receiver-operating characteristics (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
8. Cuckle HS, Wald NJ, Thompson S. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. BJOG 1987;94:387-402.
9. Nadel AS, Bromley B, Frigoletto FD, Benacerraf BR. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med 1995;14:297-302.
10. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: Description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998;12:8-14.
11. Vergani P, Locatelli A, Piccoli MG, Ceruti P, Mariani E, Pezzullo JC, et al. Best second trimester sonographic markers for the detection of trisomy 21. J Ultrasound Med 1999;18:469-73.
12. Snijders RJ, Noble P, Sabre N, Souka A, Nicolaides KH. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343-6.
13. Vintzileos AM, Ananth CV, Fisher AJ, Smulian JC, Day-Salvatore D, Beazoglou T, et al. An economic evaluation of second-trimester genetic ultrasonography for prenatal detection of Down syndrome. Am J Obstet Gynecol 1998;179:1214-9.
14. Spencer K. The measurement of hCG subunits in screening for Down's syndrome. In: Grudzinskas JG, Chard T, Chapman M, Cuckle H, editors. Screening for Down's Syndrome. Cambridge (UK): Cambridge University Press; 1945. p. 85-100.